BioCentury
ARTICLE | Financial News

Synta completes direct public offering

December 17, 2012 8:00 AM UTC

Synta Pharmaceuticals Corp. (NASDAQ:SNTA), Lexington, Mass. Business: Cancer, Autoimmune Date completed: 12/13/12 Type: Direct public offering Raised: $60.2 million Shares: 7 million Price: $8.60 Shar...